Login / Signup

Cryopreservation of Fetal Porcine Kidneys for Xenogeneic Regenerative Medicine.

Kenji MatsuiYoshitaka KinoshitaYuka InageNaoto MatsumotoKeita MorimotoYatsumu SaitoTsuyoshi TakamuraHitomi MatsunariShuichiro YamanakaHiroshi NagashimaKobayashi EijiTakashi Yokoo
Published in: Journal of clinical medicine (2023)
Kidney xenotransplantation has been attracting attention as a treatment option for end-stage renal disease. Fetal porcine kidneys are particularly promising grafts because they can reduce rejection through vascularization from host vessels. We are proposing xenogeneic regenerative medicine using fetal porcine kidneys injected with human nephron progenitor cells. For clinical application, it is desirable to establish reliable methods for the preservation and quality assessment of grafts. We evaluated the differentiation potency of vitrified porcine fetal kidneys compared with nonfrozen kidneys, using an in vivo differentiation model. Fetal porcine kidneys connected to the bladder were frozen via vitrification and stored in liquid nitrogen. Several days later, they were thawed and transplanted under the retroperitoneum of immunocompromised mice. After 14 days, the frozen kidneys grew and differentiated into mature nephrons, and the findings were comparable to those of nonfrozen kidneys. In conclusion, we demonstrated that the differentiation potency of vitrified fetal porcine kidneys could be evaluated using this model, thereby providing a practical protocol to assess the quality of individual lots.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • randomized controlled trial
  • endothelial cells
  • type diabetes
  • spinal cord injury
  • urinary tract
  • ionic liquid
  • combination therapy